IL6 and urticaria: Since urticaria activity often changes, overall disease activity is best measured by the daily UAS and serum IL-6 (a better indicator of short-term snapshots of disease severity (once-daily UAS)), and disease impact on quality of life, by the DLQI, as supported by our study.